Announcements Trials
Browse Landscape

Phase

Phase 2 14Phase 1 8Phase 1/2 7Phase 3 6Phase 4 3

Status

Completed 3

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Other hematologic neoplasm 3Lymphoid 3

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 3Leukemia, Promyelocytic, Acute 2Thyroid Cancer, Papillary 1Neuromyelitis Optica 1Myelitis, Transverse 1Leukemia, Myeloid, Acute 1Demyelinating Autoimmune Diseases, CNS 1Autoimmune Diseases of the Nervous System 1

Interventions

Vincristine 20Cytarabine 19Methotrexate 18Dexamethasone 17Cyclophosphamide 17Mercaptopurine 16Daunorubicin 12Asparaginase 12Doxorubicin 10Prednisolone 9Granulocyte Colony-Stimulating Factor 8Idarubicin 7Etoposide 7Thioguanine 6Teniposide 6Rituximab 6Prednisone 6Vindesine 5Ifosfamide 5Stem Cell Transplantation 4fludarabine 3Mitoxantrone 3Hydrocortisone 3pegaspargase 2Ketamine 2Inotuzumab Ozogamicin 2Imatinib Mesylate 2Cladribine 2Cholecalciferol 2pegylated granulocyte colony-stimulating factor 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 4 × Precursor Cell Lymphoblastic Leukemia-Lymphoma × Mitoxantrone × Clear all
NCT00199069 2023-03-17

German Multicenter Trial for Treatment of Newly Diagnosed Acute Lymphoblastic Leukemia in Adults (05/93)

Goethe University

Phase 4 Completed
720 enrolled
LymphoidOther hematologic neoplasm

Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT00853008 2020-04-07

LAL-AR/2003

PETHEMA Foundation

Phase 4 Completed
100 enrolled
LymphoidOther hematologic neoplasm

Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT00526305 2010-01-05

LAL-Ph-2000: Treatment of Acute Lymphoblastic Leukemia Chromosome Philadelphia Positive

PETHEMA Foundation

Phase 4 Completed
100 enrolled
LymphoidOther hematologic neoplasm

Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡